Javier Cerezo

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The clinical use of platinum(II)-based drugs incurs serious side effects due to the non-specific reactions with both malignant and normal cells. To circumvent such major drawback, novel metallodrugs might be combined with suitable carrier molecules, as antibodies, to ensure selective attacks on tumors while sparing healthy tissues. In this contribution, we(More)
  • 1